Healthcare provider profile · identity verified

Charles J Wu, MD

Internal Medicine · CLEVELAND, OH · NPI 1326138439

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1197	397
Lisinopril	Lisinopril	815	259
Amlodipine Besylate	Amlodipine Besylate	713	226
Losartan Potassium	Losartan Potassium	579	182
Rosuvastatin Calcium	Rosuvastatin Calcium	501	165
Levothyroxine Sodium	Levothyroxine Sodium	482	145
Metoprolol Succinate	Metoprolol Succinate	467	162
Hydrochlorothiazide	Hydrochlorothiazide	398	142
Omeprazole	Omeprazole	387	140
Metformin Hcl Er	Metformin Hcl	368	148
Tamsulosin Hcl	Tamsulosin Hcl	304	107
Jardiance	Empagliflozin	259	69
Ozempic	Semaglutide	240	57
Simvastatin	Simvastatin	203	66
Sertraline Hcl	Sertraline Hcl	195	62
Gabapentin	Gabapentin	194	75
Pantoprazole Sodium	Pantoprazole Sodium	183	61
Ezetimibe	Ezetimibe	161	63
Potassium Chloride	Potassium Chloride	156	69
Trazodone Hcl	Trazodone Hcl	145	53
Zolpidem Tartrate	Zolpidem Tartrate	144	44
Prednisone	Prednisone	128	78
Allopurinol	Allopurinol	122	40
Trulicity	Dulaglutide	120	26
Mirtazapine	Mirtazapine	119	40
Fluticasone Propionate	Fluticasone Propionate	118	48
Famotidine	Famotidine	116	44
Metoprolol Tartrate	Metoprolol Tartrate	110	37
Furosemide	Furosemide	106	29
Metformin Hcl	Metformin Hcl	106	41
Eliquis	Apixaban	101	30
Alendronate Sodium	Alendronate Sodium	99	31
Donepezil Hcl	Donepezil Hcl	97	29
Carvedilol	Carvedilol	88	34
Albuterol Sulfate Hfa	Albuterol Sulfate	79	33
Atenolol	Atenolol	79	30
Hydralazine Hcl	Hydralazine Hcl	75	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	25
Tramadol Hcl	Tramadol Hcl	69	26
Mounjaro	Tirzepatide	68	18
Meloxicam	Meloxicam	67	28
Finasteride	Finasteride	66	24
Bupropion Xl	Bupropion Hcl	65	16
Glimepiride	Glimepiride	62	26
Topiramate	Topiramate	61	33
Citalopram Hbr	Citalopram Hydrobromide	60	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	60	21
Alprazolam	Alprazolam	59	26
Spironolactone	Spironolactone	59	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	56	16
Lorazepam	Lorazepam	56	29
Clopidogrel	Clopidogrel Bisulfate	55	15
Montelukast Sodium	Montelukast Sodium	54	17
Xarelto	Rivaroxaban	50	13
Synthroid	Levothyroxine Sodium	47	22
Warfarin Sodium	Warfarin Sodium	46	12
Duloxetine Hcl	Duloxetine Hcl	45	15
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	41	34
Escitalopram Oxalate	Escitalopram Oxalate	39	14
Chlorthalidone	Chlorthalidone	38	12
Buspirone Hcl	Buspirone Hcl	36	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	suppressed
Colchicine	Colchicine	31	17
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	31	20
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	31	suppressed
Ibuprofen	Ibuprofen	30	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	23
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Sod Sulf-Potass Sulf-Mag Sulf	Sodium, Potassium,mag Sulfates	26	26
Benazepril Hcl	Benazepril Hcl	24	suppressed
Minoxidil	Minoxidil	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	12
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Azelastine Hcl	Azelastine Hcl	21	14
Doxycycline Monohydrate	Doxycycline Monohydrate	21	17
Paxlovid	Nirmatrelvir/Ritonavir	21	21
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Amoxicillin	Amoxicillin	19	15
Glipizide	Glipizide	19	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Azithromycin	Azithromycin	18	16
Baclofen	Baclofen	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Torsemide	Torsemide	18	suppressed
Valsartan	Valsartan	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	14
Nadolol	Nadolol	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Testosterone Cypionate	Testosterone Cypionate	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	13
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Jantoven	Warfarin Sodium	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Clonazepam	Clonazepam	13	suppressed
Fluocinonide	Fluocinonide	13	suppressed
Ramipril	Ramipril	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Methylprednisolone	Methylprednisolone	12	11
Acyclovir	Acyclovir	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Estradiol	Estradiol	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Rexulti	Brexpiprazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error